Global Advanced Wound Care Market - Trends and Forecast to 2024
Synopsis:
Global Advanced Wound Care Market is expected to reach USD 22,088.6 billion by 2024 from USD 11,683.5 billion in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024. The report contains 403 pages of exclusive premium insights with 434 tables and 25 figures.
Wound care management is a growing field that has been witnessing a number of technological advancements in recent years. There are various products available in the market which has made treatment of wounds easier. The companies operating in the global advanced wound care market are focusing on incorporating advanced and innovative features in their products to differentiate them from other products available in the market. Companies operating in this market are focusing on acquisitions to strengthen their product portfolio and enhance their market position.
The Global Advanced Wound Care Market has been segmented On the basis of type the market is segmented into On the basis of type the advanced wound care market is segmented into dressings, biologics and therapy devices. The advanced wound care dressings market is further segmented on the basis of product type into foam dressings, film dressings, hydrogels, alginates, wound contact layers and super absorbent dressings. The advanced wound care biologics market segment is sub-segment into allografts, synthetic skin grafts, xenografts, and growth factors. The Therapy devices segment is further classified on the basis of product type into NPWT devices, pressure relief devices, hyperbaric oxygen chambers (HBOT), wound debridement devices and physical therapies.
Based on end users, the market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.
The global advanced wound care market is segmented into geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. These regions are further classified on the basis of country, into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Major Players Operating in this market:
3M, Smith and Nephew, Medtronic, Acelity L.P. INC, Molnlycke Healthcare AB, Convatec Inc., Baxter, ColoplaHst, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, Mimedx Group, Organogenesis Inc, Talley Group, BSN Medical, Devon Medical Products, Human Biosciences Inc, B.Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries, LLC, MPM Medical Inc, Kinetic Concepts, Advancis Medical
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America),Middle East and Africa)).
Global Advanced Wound Care Market is expected to reach USD 22,088.6 billion by 2024 from USD 11,683.5 billion in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024. The report contains 403 pages of exclusive premium insights with 434 tables and 25 figures.
Wound care management is a growing field that has been witnessing a number of technological advancements in recent years. There are various products available in the market which has made treatment of wounds easier. The companies operating in the global advanced wound care market are focusing on incorporating advanced and innovative features in their products to differentiate them from other products available in the market. Companies operating in this market are focusing on acquisitions to strengthen their product portfolio and enhance their market position.
The Global Advanced Wound Care Market has been segmented On the basis of type the market is segmented into On the basis of type the advanced wound care market is segmented into dressings, biologics and therapy devices. The advanced wound care dressings market is further segmented on the basis of product type into foam dressings, film dressings, hydrogels, alginates, wound contact layers and super absorbent dressings. The advanced wound care biologics market segment is sub-segment into allografts, synthetic skin grafts, xenografts, and growth factors. The Therapy devices segment is further classified on the basis of product type into NPWT devices, pressure relief devices, hyperbaric oxygen chambers (HBOT), wound debridement devices and physical therapies.
Based on end users, the market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.
The global advanced wound care market is segmented into geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. These regions are further classified on the basis of country, into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Major Players Operating in this market:
3M, Smith and Nephew, Medtronic, Acelity L.P. INC, Molnlycke Healthcare AB, Convatec Inc., Baxter, ColoplaHst, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, Mimedx Group, Organogenesis Inc, Talley Group, BSN Medical, Devon Medical Products, Human Biosciences Inc, B.Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries, LLC, MPM Medical Inc, Kinetic Concepts, Advancis Medical
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America),Middle East and Africa)).
1 INTRODUCTION
1.1. OVERVIEW OF THE ADVANCED WOUND CARE MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE ADVANCED WOUND CARE MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. KEY DATA POINTS FROM PRIMARY SOURCE
2.2.4. KEY DATA POINTS FROM SECONDARY SOURCE
2.2.5. MARKET CRACKDOWN APPROACH
2.2.6. FOCUS GROUP STUDIES
2.2.7. EPIDEMIOLOGICAL FORECAST MODELLING
2.2.8. MARKET PENETRATION MATRIX
2.3 ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 MARKET OVERVIEW
4.1. OVERVIEW
4.2. ADVANCED WOUND CARE MARKET: KEY PRIMARY INSIGHTS
4.3. DRIVERS, OPPORTUNITIES AND THREAT ANALYSIS MATRIX
4.4. KEY MARKET FINDINGS
4.5. NEW REGULATORY POLICIES
5 ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.2 ADVANCED WOUND CARE DRESSINGS, BY TYPE
5.2.1 FOAM DRESSINGS
5.2.2 HYDROCOLLOIDS
5.2.3 HYDROFIBER
5.2.4 FILM DRESSINGS
5.2.5 ALGINATES
5.2.6 COLLAGEN
5.2.7 HYDROGELS
5.2.8 WOUND CONTACT LAYERS
5.2.9 SUPERABSORBENT DRESSINGS
5.3 WOUND CARE THERAPY DEVICES, BY TYPE
5.3.1 NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)
5.3.1.1 STAND-ALONE NPWT DEVICES
5.3.1.2 PORTABLE NPWT DEVICES
5.3.1.3 DISPOSABLE NPWT DEVICES
5.3.2 HYBERBARIC OXYGEN CHAMBERS
5.3.3 WOUND DEBRIDEMENT DEVICES
5.3.4 OTHERS
5.4 ACTIVE WOUND CARE, BY TYPE
5.4.1 GROWTH FACTORS
5.4.2 COMPOSITE SKIN GRAFTS
5.4.3 BIOLOGIC GRAFTS
6 ADVANCED WOUND CARE MARKET, BY INDICATION
6.1. OVERVIEW
6.2. DIABETIC ULCERS
6.2.1. PATEINT POOL, BY GEOGRAPHY
6.2.2. MARKET TRENDS, BY GEOGRAPHY
6.3. VENOUS ULCERS
6.3.1. PATEINT POOL, BY GEOGRAPHY
6.3.2. MARKET TRENDS, BY GEOGRAPHY
6.4. PRESSURE ULCERS
6.4.1. PATEINT POOL, BY GEOGRAPHY
6.4.2. MARKET TRENDS, BY GEOGRAPHY
6.5. SURGICAL WOUNDS
6.5.1. PATEINT POOL, BY GEOGRAPHY
6.5.2. MARKET TRENDS, BY GEOGRAPHY
6.6. TRAUMATIC WOUNDS
6.6.1. PATEINT POOL, BY GEOGRAPHY
6.6.2. MARKET TRENDS, BY GEOGRAPHY
6.7. BURN WOUNDS
6.7.1. PATEINT POOL, BY GEOGRAPHY
6.7.2. MARKET TRENDS, BY GEOGRAPHY
6.8. OTHER INDICATIONS
7 ADVANCED WOUND CARE MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS AND LONG TERM CARE CENTERS
7.3. WOUND CARE AND AMBULATORY SURGICAL CENTERS
7.4. HOME HEALTHCARE SETTINGS
7.5. OTHERS
8 ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE ADVANCED WOUND CARE MARKET BY (PRODUCT TYPE, INDICATION, END-USER)
8.1.1. NORTH AMERICA
8.1.1.1. U.S.
8.1.1.2. CANADA
8.1.1.3. MEXICO
8.1.2. EUROPE
8.1.2.1. GERMANY
8.1.2.2. FRANCE
8.1.2.3. U.K.
8.1.2.4. ITALY
8.1.2.5. SPAIN
8.1.2.6. RUSSIA
8.1.2.7. TURKEY
8.1.2.8. BELGIUM
8.1.2.9. NETHERLANDS
8.1.2.10. SWITZERLAND
8.1.2.11. REST OF EUROPE
8.1.3. ASIA-PACIFIC (APAC)
8.1.3.1. JAPAN
8.1.3.2. CHINA
8.1.3.3. SOUTH KOREA
8.1.3.4. INDIA
8.1.3.5. AUSTRALIA
8.1.3.6. SINGAPORE
8.1.3.7. REST OF APAC
8.1.4. SOUTH AMERICA
8.1.4.1. BRAZIL
8.1.4.2. OTHERS
8.1.5. MIDDLE EAST AND AFRICA
8.2. KEY PRIMARY INSIGHTS: BY COUNTRY
9 ADVANCED WOUND CARE MARKET: COMPETITIVE LANDSCAPE
9.1. ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.2. NORTH AMERICA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.4. APAC ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.5. ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.6. NORTH AMERICA ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.7. EUROPE ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.8. APAC ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.9. NPWT MARKET: COMPANY SHARE ANALYSIS
9.10. NORTH AMERICA NPWT MARKET: COMPANY SHARE ANALYSIS
9.11. EUROPE NPWT MARKET: COMPANY SHARE ANALYSIS
9.12. APAC NPWT MARKET: COMPANY SHARE ANALYSIS
9.13. MERGERS & ACQUISITIONS
9.14. NEW PRODUCT DEVELOPMENT & APPROVALS
9.15. EXPANSIONS
9.16. REGULATORY CHANGES
9.17. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10 ADVANCED WOUND CARE MARKET, COMPANY PROFILES
10.1 3M HEALTHCARE
10.1.1 OVERVIEW
10.1.2 SWOT ANALYSIS
10.1.3 PRODUCT PORTFOLIO
10.1.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.2 SMITH AND NEPHEW
10.2.1 OVERVIEW
10.2.2 SWOT ANALYSIS
10.2.3 PRODUCT PORTFOLIO
10.2.4 REVENUE ANALYSIS
10.2.5 ANALYSTS VIEW
10.3 MEDTRONIC
10.3.1 OVERVIEW
10.3.2 SWOT ANALYSIS
10.3.3 PRODUCT PORTFOLIO
10.3.4 REVENUE ANALYSIS
10.3.5 ANALYST VIEW
10.4 KINETIC CONCEPTS, INC. ( A ACELITY COMPANY)
10.4.1 OVERVIEW
10.4.2 SWOT ANALYSIS
10.4.3 PRODUCT PORTFOLIO
10.4.4 REVENUE ANALYSIS
10.4.5 ANALYSTS VIEW
10.5 MOLYNCKE HEALTHCARE
10.5.1 OVERVIEW
10.5.2 SWOT ANALYSIS
10.5.3 PRODUCT PORTFOLIO
10.5.4 REVENUE ANALYSIS
10.5.5 ANALYSTS VIEW
10.6 CONVATEC, INC.
10.6.1 OVERVIEW
10.6.2 SWOT ANALYSIS
10.6.3 PRODUCT PORTFOLIO
10.6.4 REVENUE ANALYSIS
10.6.5 ANALYSTS VIEW
10.7 SYSTAGENIX (A ACELITY COMPANY)
10.7.1 OVERVIEW
10.7.2 SWOT ANALYSIS
10.7.3 PRODUCT PORTFOLIO
10.7.4 REVENUE ANALYSIS
10.7.5 ANALYSTS VIEW
10.8 BAXTER INTERNATIONAL, INC.
10.8.1 OVERVIEW
10.8.2 SWOT ANALYSIS
10.8.3 PRODUCT PORTFOLIO
10.8.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.9 COLOPLAST
10.9.1 OVERVIEW
10.9.2 SWOT ANALYSIS
10.9.3 PRODUCT PORTFOLIO
10.9.4 REVENUE ANALYSIS
10.9.5 ANALYSTS VIEW
10.10 ETHICON, INC.
10.10.1 OVERVIEW
10.10.2 SWOT ANALYSIS
10.10.3 PRODUCT PORTFOLIO
10.10.4 REVENUE ANALYSIS
10.10.5 ANALYSTS VIEW
10.11 HOLLISTER, INC.
10.11.1 OVERVIEW
10.11.2 SWOT ANALYSIS
10.11.3 PRODUCT PORTFOLIO
10.11.4 REVENUE ANALYSIS
10.11.5 ANALYSTS VIEW
10.12 INTEGRA LIFESCIENCES
10.12.1 OVERVIEW
10.12.2 SWOT ANALYSIS
10.12.3 PRODUCT PORTFOLIO
10.12.4 REVENUE ANALYSIS
10.12.5 ANALYSTS VIEW
10.13 DERMA SCIENCES
10.13.1 OVERVIEW
10.13.2 SWOT ANALYSIS
10.13.3 PRODUCT PORTFOLIO
10.13.4 REVENUE ANALYSIS
10.13.5 ANALYSTS VIEW
10.14 SPIRACUR, INC.
10.14.1 OVERVIEW
10.14.2 SWOT ANALYSIS
10.14.3 PRODUCT PORTFOLIO
10.14.4 REVENUE ANALYSIS
10.14.5 ANALYSTS VIEW
10.15 DEVON MEDICAL PRODUCTS
10.15.1 OVERVIEW
10.15.2 SWOT ANALYSIS
10.15.3 PRODUCT PORTFOLIO
10.15.4 REVENUE ANALYSIS
10.15.5 ANALYSTS VIEW
10.16 MEDLINE INDUSTRIES
10.16.1 OVERVIEW
10.16.2 SWOT ANALYSIS
10.16.3 PRODUCT PORTFOLIO
10.16.4 REVENUE ANALYSIS
10.16.5 ANALYSTS VIEW
10.17 BSN MEDICAL
10.17.1 OVERVIEW
10.17.2 SWOT ANALYSIS
10.17.3 PRODUCT PORTFOLIO
10.17.4 REVENUE ANALYSIS
10.17.5 ANALYSTS VIEW
10.18 ORGANOGENESIS, INC.
10.18.1 OVERVIEW
10.18.2 SWOT ANALYSIS
10.18.3 PRODUCT PORTFOLIO
10.18.4 REVENUE ANALYSIS
10.18.5 ANALYSTS VIEW
10.19 TALLEY GROUP
10.19.1 OVERVIEW
10.19.2 SWOT ANALYSIS
10.19.3 PRODUCT PORTFOLIO
10.19.4 REVENUE ANALYSIS
10.19.5 ANALYSTS VIEW
10.20 MIMEDX
10.20.1 OVERVIEW
10.20.2 SWOT ANALYSIS
10.20.3 PRODUCT PORTFOLIO
10.20.4 REVENUE ANALYSIS
10.20.5 ANALYSTS VIEW
1.1. OVERVIEW OF THE ADVANCED WOUND CARE MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE ADVANCED WOUND CARE MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. KEY DATA POINTS FROM PRIMARY SOURCE
2.2.4. KEY DATA POINTS FROM SECONDARY SOURCE
2.2.5. MARKET CRACKDOWN APPROACH
2.2.6. FOCUS GROUP STUDIES
2.2.7. EPIDEMIOLOGICAL FORECAST MODELLING
2.2.8. MARKET PENETRATION MATRIX
2.3 ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 MARKET OVERVIEW
4.1. OVERVIEW
4.2. ADVANCED WOUND CARE MARKET: KEY PRIMARY INSIGHTS
4.3. DRIVERS, OPPORTUNITIES AND THREAT ANALYSIS MATRIX
4.4. KEY MARKET FINDINGS
4.5. NEW REGULATORY POLICIES
5 ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.2 ADVANCED WOUND CARE DRESSINGS, BY TYPE
5.2.1 FOAM DRESSINGS
5.2.2 HYDROCOLLOIDS
5.2.3 HYDROFIBER
5.2.4 FILM DRESSINGS
5.2.5 ALGINATES
5.2.6 COLLAGEN
5.2.7 HYDROGELS
5.2.8 WOUND CONTACT LAYERS
5.2.9 SUPERABSORBENT DRESSINGS
5.3 WOUND CARE THERAPY DEVICES, BY TYPE
5.3.1 NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)
5.3.1.1 STAND-ALONE NPWT DEVICES
5.3.1.2 PORTABLE NPWT DEVICES
5.3.1.3 DISPOSABLE NPWT DEVICES
5.3.2 HYBERBARIC OXYGEN CHAMBERS
5.3.3 WOUND DEBRIDEMENT DEVICES
5.3.4 OTHERS
5.4 ACTIVE WOUND CARE, BY TYPE
5.4.1 GROWTH FACTORS
5.4.2 COMPOSITE SKIN GRAFTS
5.4.3 BIOLOGIC GRAFTS
6 ADVANCED WOUND CARE MARKET, BY INDICATION
6.1. OVERVIEW
6.2. DIABETIC ULCERS
6.2.1. PATEINT POOL, BY GEOGRAPHY
6.2.2. MARKET TRENDS, BY GEOGRAPHY
6.3. VENOUS ULCERS
6.3.1. PATEINT POOL, BY GEOGRAPHY
6.3.2. MARKET TRENDS, BY GEOGRAPHY
6.4. PRESSURE ULCERS
6.4.1. PATEINT POOL, BY GEOGRAPHY
6.4.2. MARKET TRENDS, BY GEOGRAPHY
6.5. SURGICAL WOUNDS
6.5.1. PATEINT POOL, BY GEOGRAPHY
6.5.2. MARKET TRENDS, BY GEOGRAPHY
6.6. TRAUMATIC WOUNDS
6.6.1. PATEINT POOL, BY GEOGRAPHY
6.6.2. MARKET TRENDS, BY GEOGRAPHY
6.7. BURN WOUNDS
6.7.1. PATEINT POOL, BY GEOGRAPHY
6.7.2. MARKET TRENDS, BY GEOGRAPHY
6.8. OTHER INDICATIONS
7 ADVANCED WOUND CARE MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS AND LONG TERM CARE CENTERS
7.3. WOUND CARE AND AMBULATORY SURGICAL CENTERS
7.4. HOME HEALTHCARE SETTINGS
7.5. OTHERS
8 ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE ADVANCED WOUND CARE MARKET BY (PRODUCT TYPE, INDICATION, END-USER)
8.1.1. NORTH AMERICA
8.1.1.1. U.S.
8.1.1.2. CANADA
8.1.1.3. MEXICO
8.1.2. EUROPE
8.1.2.1. GERMANY
8.1.2.2. FRANCE
8.1.2.3. U.K.
8.1.2.4. ITALY
8.1.2.5. SPAIN
8.1.2.6. RUSSIA
8.1.2.7. TURKEY
8.1.2.8. BELGIUM
8.1.2.9. NETHERLANDS
8.1.2.10. SWITZERLAND
8.1.2.11. REST OF EUROPE
8.1.3. ASIA-PACIFIC (APAC)
8.1.3.1. JAPAN
8.1.3.2. CHINA
8.1.3.3. SOUTH KOREA
8.1.3.4. INDIA
8.1.3.5. AUSTRALIA
8.1.3.6. SINGAPORE
8.1.3.7. REST OF APAC
8.1.4. SOUTH AMERICA
8.1.4.1. BRAZIL
8.1.4.2. OTHERS
8.1.5. MIDDLE EAST AND AFRICA
8.2. KEY PRIMARY INSIGHTS: BY COUNTRY
9 ADVANCED WOUND CARE MARKET: COMPETITIVE LANDSCAPE
9.1. ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.2. NORTH AMERICA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.4. APAC ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
9.5. ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.6. NORTH AMERICA ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.7. EUROPE ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.8. APAC ADVANCED WOUND CARE DRESSINGS MARKET: COMPANY SHARE ANALYSIS
9.9. NPWT MARKET: COMPANY SHARE ANALYSIS
9.10. NORTH AMERICA NPWT MARKET: COMPANY SHARE ANALYSIS
9.11. EUROPE NPWT MARKET: COMPANY SHARE ANALYSIS
9.12. APAC NPWT MARKET: COMPANY SHARE ANALYSIS
9.13. MERGERS & ACQUISITIONS
9.14. NEW PRODUCT DEVELOPMENT & APPROVALS
9.15. EXPANSIONS
9.16. REGULATORY CHANGES
9.17. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10 ADVANCED WOUND CARE MARKET, COMPANY PROFILES
10.1 3M HEALTHCARE
10.1.1 OVERVIEW
10.1.2 SWOT ANALYSIS
10.1.3 PRODUCT PORTFOLIO
10.1.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.2 SMITH AND NEPHEW
10.2.1 OVERVIEW
10.2.2 SWOT ANALYSIS
10.2.3 PRODUCT PORTFOLIO
10.2.4 REVENUE ANALYSIS
10.2.5 ANALYSTS VIEW
10.3 MEDTRONIC
10.3.1 OVERVIEW
10.3.2 SWOT ANALYSIS
10.3.3 PRODUCT PORTFOLIO
10.3.4 REVENUE ANALYSIS
10.3.5 ANALYST VIEW
10.4 KINETIC CONCEPTS, INC. ( A ACELITY COMPANY)
10.4.1 OVERVIEW
10.4.2 SWOT ANALYSIS
10.4.3 PRODUCT PORTFOLIO
10.4.4 REVENUE ANALYSIS
10.4.5 ANALYSTS VIEW
10.5 MOLYNCKE HEALTHCARE
10.5.1 OVERVIEW
10.5.2 SWOT ANALYSIS
10.5.3 PRODUCT PORTFOLIO
10.5.4 REVENUE ANALYSIS
10.5.5 ANALYSTS VIEW
10.6 CONVATEC, INC.
10.6.1 OVERVIEW
10.6.2 SWOT ANALYSIS
10.6.3 PRODUCT PORTFOLIO
10.6.4 REVENUE ANALYSIS
10.6.5 ANALYSTS VIEW
10.7 SYSTAGENIX (A ACELITY COMPANY)
10.7.1 OVERVIEW
10.7.2 SWOT ANALYSIS
10.7.3 PRODUCT PORTFOLIO
10.7.4 REVENUE ANALYSIS
10.7.5 ANALYSTS VIEW
10.8 BAXTER INTERNATIONAL, INC.
10.8.1 OVERVIEW
10.8.2 SWOT ANALYSIS
10.8.3 PRODUCT PORTFOLIO
10.8.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.9 COLOPLAST
10.9.1 OVERVIEW
10.9.2 SWOT ANALYSIS
10.9.3 PRODUCT PORTFOLIO
10.9.4 REVENUE ANALYSIS
10.9.5 ANALYSTS VIEW
10.10 ETHICON, INC.
10.10.1 OVERVIEW
10.10.2 SWOT ANALYSIS
10.10.3 PRODUCT PORTFOLIO
10.10.4 REVENUE ANALYSIS
10.10.5 ANALYSTS VIEW
10.11 HOLLISTER, INC.
10.11.1 OVERVIEW
10.11.2 SWOT ANALYSIS
10.11.3 PRODUCT PORTFOLIO
10.11.4 REVENUE ANALYSIS
10.11.5 ANALYSTS VIEW
10.12 INTEGRA LIFESCIENCES
10.12.1 OVERVIEW
10.12.2 SWOT ANALYSIS
10.12.3 PRODUCT PORTFOLIO
10.12.4 REVENUE ANALYSIS
10.12.5 ANALYSTS VIEW
10.13 DERMA SCIENCES
10.13.1 OVERVIEW
10.13.2 SWOT ANALYSIS
10.13.3 PRODUCT PORTFOLIO
10.13.4 REVENUE ANALYSIS
10.13.5 ANALYSTS VIEW
10.14 SPIRACUR, INC.
10.14.1 OVERVIEW
10.14.2 SWOT ANALYSIS
10.14.3 PRODUCT PORTFOLIO
10.14.4 REVENUE ANALYSIS
10.14.5 ANALYSTS VIEW
10.15 DEVON MEDICAL PRODUCTS
10.15.1 OVERVIEW
10.15.2 SWOT ANALYSIS
10.15.3 PRODUCT PORTFOLIO
10.15.4 REVENUE ANALYSIS
10.15.5 ANALYSTS VIEW
10.16 MEDLINE INDUSTRIES
10.16.1 OVERVIEW
10.16.2 SWOT ANALYSIS
10.16.3 PRODUCT PORTFOLIO
10.16.4 REVENUE ANALYSIS
10.16.5 ANALYSTS VIEW
10.17 BSN MEDICAL
10.17.1 OVERVIEW
10.17.2 SWOT ANALYSIS
10.17.3 PRODUCT PORTFOLIO
10.17.4 REVENUE ANALYSIS
10.17.5 ANALYSTS VIEW
10.18 ORGANOGENESIS, INC.
10.18.1 OVERVIEW
10.18.2 SWOT ANALYSIS
10.18.3 PRODUCT PORTFOLIO
10.18.4 REVENUE ANALYSIS
10.18.5 ANALYSTS VIEW
10.19 TALLEY GROUP
10.19.1 OVERVIEW
10.19.2 SWOT ANALYSIS
10.19.3 PRODUCT PORTFOLIO
10.19.4 REVENUE ANALYSIS
10.19.5 ANALYSTS VIEW
10.20 MIMEDX
10.20.1 OVERVIEW
10.20.2 SWOT ANALYSIS
10.20.3 PRODUCT PORTFOLIO
10.20.4 REVENUE ANALYSIS
10.20.5 ANALYSTS VIEW
